• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在生殖细胞肿瘤诊断及临床管理中的当前作用

Current Role of MicroRNAs in the Diagnosis and Clinical Management of Germ Cell Tumors.

作者信息

Tavares Nuno Tiago, Henrique Rui, Jerónimo Carmen, Lobo João

机构信息

Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC) & CI-IPOP@RISE (Health Research Network), IPO Porto, Research Center, CI-LAB3, 1st Floor, F Building. Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Doctoral Programme in Biomedical Sciences, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, Porto 4050-513, Portugal.

Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC) & CI-IPOP@RISE (Health Research Network), IPO Porto, Research Center, CI-LAB3, 1st Floor, F Building. Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Pathology and Molecular Immunology, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira 228, Porto 4050-513, Portugal; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal.

出版信息

Surg Pathol Clin. 2025 Mar;18(1):91-100. doi: 10.1016/j.path.2024.08.003. Epub 2024 Dec 3.

DOI:10.1016/j.path.2024.08.003
PMID:39890312
Abstract

Germ cell tumors (GCTs) are a rare and heterogeneous group of neoplasms arising from primitive germ cells. MicroRNAs are small noncoding RNAs that have emerged as potential cancer biomarkers in the last decade. In particular, miR-371a-3p has shown good diagnostic performance for germ cell neoplasia in situ-derived testicular GCTs in several well-established cohorts and is expected to enter the clinical arena in the near future. GCTs universally exhibit high expression of miR-371-373 and miR-302/367 clusters and low expression of let-7 family miRNAs. Further studies are needed to assess the potential role of these miRNAs as biomarkers of ovarian and extragonadal GCTs.

摘要

生殖细胞肿瘤(GCTs)是一组罕见且异质性的肿瘤,起源于原始生殖细胞。微小RNA是一类小的非编码RNA,在过去十年中已成为潜在的癌症生物标志物。特别是,miR-371a-3p在几个成熟的队列研究中对原位生殖细胞肿瘤衍生的睾丸GCTs显示出良好的诊断性能,预计在不久的将来进入临床应用。GCTs普遍表现出miR-371-373和miR-302/367簇的高表达以及let-7家族微小RNA的低表达。需要进一步研究来评估这些微小RNA作为卵巢和性腺外GCTs生物标志物的潜在作用。

相似文献

1
Current Role of MicroRNAs in the Diagnosis and Clinical Management of Germ Cell Tumors.微小RNA在生殖细胞肿瘤诊断及临床管理中的当前作用
Surg Pathol Clin. 2025 Mar;18(1):91-100. doi: 10.1016/j.path.2024.08.003. Epub 2024 Dec 3.
2
Biology of childhood germ cell tumours, focussing on the significance of microRNAs.儿童生殖细胞肿瘤的生物学,聚焦于微小RNA的重要性。
Andrology. 2015 Jan;3(1):129-39. doi: 10.1111/andr.277. Epub 2014 Oct 9.
3
Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?通过检测血清微小RNA371a - 3p水平能否诊断原位生殖细胞肿瘤?
J Cancer Res Clin Oncol. 2017 Nov;143(11):2383-2392. doi: 10.1007/s00432-017-2490-7. Epub 2017 Aug 17.
4
The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis.miR-371a-3p 对睾丸生殖细胞肿瘤的诊断准确性:系统评价和荟萃分析。
Mol Diagn Ther. 2021 May;25(3):273-281. doi: 10.1007/s40291-021-00521-x. Epub 2021 Apr 22.
5
Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.miR-371a-3p 预睾丸切除术在睾丸生殖细胞肿瘤管理中的实际应用。
J Urol. 2021 Jan;205(1):137-144. doi: 10.1097/JU.0000000000001337. Epub 2020 Aug 28.
6
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.一种用于定量血清和脑脊液微小RNA以诊断和检测小儿恶性生殖细胞肿瘤复发的流程。
Br J Cancer. 2016 Jan 19;114(2):151-62. doi: 10.1038/bjc.2015.429. Epub 2015 Dec 15.
7
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.血清 miR-371a-3p 在预测临床Ⅰ期睾丸生殖细胞癌患者监测复发中的应用。
Eur Urol Oncol. 2021 Jun;4(3):483-491. doi: 10.1016/j.euo.2020.11.004. Epub 2020 Dec 4.
8
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review.循环 microRNAs:睾丸生殖细胞肿瘤的下一代血清生物标志物:系统综述。
Eur Urol. 2021 Oct;80(4):456-466. doi: 10.1016/j.eururo.2021.06.006. Epub 2021 Jun 24.
9
microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.微小RNA-371a-3p作为睾丸生殖细胞癌患者随访的信息性生物标志物。
Cell Oncol (Dordr). 2017 Aug;40(4):379-388. doi: 10.1007/s13402-017-0333-9. Epub 2017 Jun 13.
10
Diagnostic performance of microRNAs in testicular germ cell tumors: a systematic review and meta-analysis.microRNAs 在睾丸生殖细胞肿瘤中的诊断性能:系统评价和荟萃分析。
Aging (Albany NY). 2021 Aug 3;13(15):19657-19677. doi: 10.18632/aging.203376.

引用本文的文献

1
MicroRNA-371-373 cluster extracellular vesicle-based communication in testicular germ cell tumors.基于细胞外囊泡的MicroRNA-371-373簇在睾丸生殖细胞肿瘤中的通讯
Cell Commun Signal. 2025 May 30;23(1):252. doi: 10.1186/s12964-025-02250-8.